In the morning on November 12, 2019, the Stock Exchange of Thailand has lifted the “SP” sign from DOD Biotech Public Company Limited (DOD)’s securities after the company had submitted its 3Q19 financial statement.
DOD reported a net profit in the quarter at 20.03 million baht, plunged 72.50% when compared to the same quarter of last year. Still, the net profit reported by DOD last night was better than the number that got mistakenly revealed from the SET yesterday morning.
The company has revenue from sales and services in the 3Q19 in the amount of 217.59 million baht, an increase of 60.40 million baht in the same period of the previous year or 38.42%.
The total assets of the company as of 30 September 2019 were 1,642.47 million baht, an increase of 235.82 million baht or 16.76% compared to 1,406.65 million baht as of December 31, 2018 due to goodwill from the purchase of PPCA Laboratory Company Limited in the amount of 108 million baht to invest in PPCA Laboratory, a company that produces and sells cosmetics. Which is a way to increase revenue and profits for the company in the future and increase in trade receivables in the amount of 162.96 million baht.
The shareholders’ equity of DOD as of 30 September 2019 is 1,282.24 million baht, an increase of 97.92 million baht or 8.27% compared to the date of 31 December 2018 at 1,184.32 million baht due to DOD’s net profit during the nine month period in the amount of 79.79 million baht and the increase in shareholders’ equity DOD-W1 warrants in the amount of 18.22 million baht